Human medicines European public assessment report (EPAR): Reyataz, atazanavir sulfate, Date of authorisation: 01/03/2004, Revision: 57, Status: Authorised

Human medicines European public assessment report (EPAR): Reyataz, atazanavir sulfate, Date of authorisation: 01/03/2004, Revision: 57, Status: Authorised

Human medicines European public assessment report (EPAR): Mevlyq, eribulin, Date of authorisation: 09/02/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Mevlyq, eribulin, Date of authorisation: 09/02/2024, Revision: 1, Status: Authorised

Quarterly System Demo - Q3 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 September 2024, 09:00 (CEST) to 18 September 2024, 13:15 (CEST)

Quarterly System Demo - Q3 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 September 2024, 09:00 (CEST) to 18 September 2024, 13:15 (CEST)

Human medicines European public assessment report (EPAR): Clopidogrel Zentiva (previously Clopidogrel Winthrop), clopidogrel, Date of authorisation: 15/07/2008, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR): Clopidogrel Zentiva (previously Clopidogrel Winthrop), clopidogrel, Date of authorisation: 15/07/2008, Revision: 33, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness